{"id":"https://openalex.org/W4322769402","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd18-03","title":"Abstract PD18-03: Final analysis of the Phase III PEONY trial: long-term efficacy and safety of neoadjuvant\u2013adjuvant pertuzumab or placebo, plus trastuzumab and docetaxel, in patients with HER2-positive early or locally advanced breast cancer","display_name":"Abstract PD18-03: Final analysis of the Phase III PEONY trial: long-term efficacy and safety of neoadjuvant\u2013adjuvant pertuzumab or placebo, plus trastuzumab and docetaxel, in patients with HER2-positive early or locally advanced breast cancer","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322769402","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd18-03"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-pd18-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd18-03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-pd18-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079128498","display_name":"Zhi\u2010Ming Shao","orcid":"https://orcid.org/0000-0001-8781-2455","observed_orcids":["https://orcid.org/0000-0001-8781-2455","https://orcid.org/0009-0001-4577-5358"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]},{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhi-Ming Shao","raw_affiliation_strings":["1Fudan University Shanghai Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fudan University Shanghai Cancer Center","institution_ids":["https://openalex.org/I24943067","https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086855515","display_name":"Da Pang","orcid":"https://orcid.org/0000-0003-2853-4170","observed_orcids":["https://orcid.org/0000-0003-2853-4170"]},"institutions":[{"id":"https://openalex.org/I156144747","display_name":"Harbin Medical University","ror":"https://ror.org/05jscf583","country_code":"CN","type":"education","lineage":["https://openalex.org/I156144747"]},{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Da Pang","raw_affiliation_strings":["2Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I156144747","https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101832106","display_name":"Hongjian Yang","orcid":"https://orcid.org/0000-0003-1583-2814","observed_orcids":["https://orcid.org/0000-0003-1583-2814"]},"institutions":[{"id":"https://openalex.org/I4210165038","display_name":"University of Chinese Academy of Sciences","ror":"https://ror.org/05qbk4x57","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210165038"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongjian Yang","raw_affiliation_strings":["3Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou, China","institution_ids":["https://openalex.org/I4210165038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["4The First Hospital of Jilin University, Changchun"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4The First Hospital of Jilin University, Changchun","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100661398","display_name":"Shusen Wang","orcid":"https://orcid.org/0000-0003-0139-5780","observed_orcids":["https://orcid.org/0000-0003-0139-5780"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shusen Wang","raw_affiliation_strings":["5Sun Yat-sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Sun Yat-sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004883114","display_name":"Shude Cui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shude Cui","raw_affiliation_strings":["6Department of Breast Surgery, Affiliated Tumor Hospital of Zhengzhou University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Breast Surgery, Affiliated Tumor Hospital of Zhengzhou University","institution_ids":["https://openalex.org/I38877650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100615994","display_name":"Ning Liao","orcid":"https://orcid.org/0000-0002-1780-5652","observed_orcids":["https://orcid.org/0000-0002-1780-5652"]},"institutions":[{"id":"https://openalex.org/I4210145693","display_name":"Guangdong Academy of Medical Sciences","ror":"https://ror.org/0432p8t34","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210145693"]},{"id":"https://openalex.org/I4210153930","display_name":"Guangdong Provincial People's Hospital","ror":"https://ror.org/045kpgw45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Liao","raw_affiliation_strings":["7Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China","institution_ids":["https://openalex.org/I4210145693","https://openalex.org/I4210153930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100359987","display_name":"Yongsheng Wang","orcid":"https://orcid.org/0000-0001-6252-684X","observed_orcids":["https://orcid.org/0000-0001-6252-684X","https://orcid.org/0009-0002-1134-1815"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yong-Sheng Wang","raw_affiliation_strings":["8Shandong Cancer Hospital & Institute, Jinan, Shandong, China, China (People\u2019s Republic)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Shandong Cancer Hospital & Institute, Jinan, Shandong, China, China (People\u2019s Republic)","institution_ids":["https://openalex.org/I4210100830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034283242","display_name":"Chuan Wang","orcid":"https://orcid.org/0000-0002-4451-0788","observed_orcids":["https://orcid.org/0000-0002-4451-0788","https://orcid.org/0000-0001-5675-6737"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chuan Wang","raw_affiliation_strings":["9Shandong Cancer Hospital, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Shandong Cancer Hospital, Jinan, China","institution_ids":["https://openalex.org/I4210100830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053516664","display_name":"Yuan\u2010Ching Chang","orcid":"https://orcid.org/0000-0001-7625-606X","observed_orcids":["https://orcid.org/0000-0001-7625-606X"]},"institutions":[{"id":"https://openalex.org/I2802753785","display_name":"Mackay Memorial Hospital","ror":"https://ror.org/015b6az38","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2802753785"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Yuan-Ching Chang","raw_affiliation_strings":["10Mackay Memorial Hospital, Taipei City, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Mackay Memorial Hospital, Taipei City, Taiwan","institution_ids":["https://openalex.org/I2802753785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109682235","display_name":"Hwei-Chung Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802753785","display_name":"Mackay Memorial Hospital","ror":"https://ror.org/015b6az38","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2802753785"]},{"id":"https://openalex.org/I4210119458","display_name":"Roche (China)","ror":"https://ror.org/02hv5e369","country_code":"CN","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210119458"]}],"countries":["CN","TW"],"is_corresponding":false,"raw_author_name":"Hwei-Chung Wang","raw_affiliation_strings":["11Mackay Memorial Hospital, Taipei City, Taiwan","18Roche Product Development, Shanghai, People\u2019s Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Mackay Memorial Hospital, Taipei City, Taiwan","institution_ids":["https://openalex.org/I2802753785"]},{"raw_affiliation_string":"18Roche Product Development, Shanghai, People\u2019s Republic of China","institution_ids":["https://openalex.org/I4210119458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038041478","display_name":"Seok Yun Kang","orcid":"https://orcid.org/0000-0002-4995-9912","observed_orcids":["https://orcid.org/0000-0002-4995-9912"]},"institutions":[{"id":"https://openalex.org/I57664883","display_name":"Ajou University","ror":"https://ror.org/03tzb2h73","country_code":"KR","type":"education","lineage":["https://openalex.org/I57664883"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seok Yun Kang","raw_affiliation_strings":["12Department of Hematology\u2013Oncology, Ajou University School of Medicine, Suwon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Department of Hematology\u2013Oncology, Ajou University School of Medicine, Suwon, Republic of Korea","institution_ids":["https://openalex.org/I57664883"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021861062","display_name":"Jae Hong Seo","orcid":"https://orcid.org/0000-0002-7363-6419","observed_orcids":["https://orcid.org/0000-0002-7363-6419","https://orcid.org/0000-0001-5232-8903"]},"institutions":[{"id":"https://openalex.org/I4405258752","display_name":"Korea University Guro Hospital","ror":"https://ror.org/0154bb690","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I197347611","https://openalex.org/I2799980853","https://openalex.org/I4405258752"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jae Hong Seo","raw_affiliation_strings":["13Division of Oncology/Hematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Division of Oncology/Hematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4405258752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072445958","display_name":"Kunwei Shen","orcid":"https://orcid.org/0000-0002-1961-8666","observed_orcids":["https://orcid.org/0000-0002-1961-8666","https://orcid.org/0000-0002-3286-0035"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kunwei Shen","raw_affiliation_strings":["14Breast Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Breast Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2801556517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055817846","display_name":"Suphawat Laohawiriyakamol","orcid":"https://orcid.org/0000-0002-4055-8784","observed_orcids":["https://orcid.org/0000-0002-4055-8784"]},"institutions":[{"id":"https://openalex.org/I131868736","display_name":"Prince of Songkla University","ror":"https://ror.org/0575ycz84","country_code":"TH","type":"education","lineage":["https://openalex.org/I131868736"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Suphawat Laohawiriyakamol","raw_affiliation_strings":["15Prince of Songkla University, Hat Yai District, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Prince of Songkla University, Hat Yai District, Thailand","institution_ids":["https://openalex.org/I131868736"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076149259","display_name":"Zefei Jiang","orcid":"https://orcid.org/0000-0002-4295-0173","observed_orcids":["https://orcid.org/0000-0002-4295-0173"]},"institutions":[{"id":"https://openalex.org/I4210096476","display_name":"307th Hospital of Chinese People\u2019s Liberation Army","ror":"https://ror.org/00vrd0936","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210096476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zefei Jiang","raw_affiliation_strings":["16Medicine\u2013Oncology, The Affiliated Hospital of Military Medical Sciences (The 307th Hospital of Chinese People\u2019s Liberation Army), Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Medicine\u2013Oncology, The Affiliated Hospital of Military Medical Sciences (The 307th Hospital of Chinese People\u2019s Liberation Army), Beijing, China","institution_ids":["https://openalex.org/I4210096476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100655458","display_name":"Liang Huang","orcid":"https://orcid.org/0009-0008-9997-5129","observed_orcids":["https://orcid.org/0009-0008-9997-5129"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liang Huang","raw_affiliation_strings":["17Shanghai Cancer Centre, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Shanghai Cancer Centre, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100354431","display_name":"Haiyan Wang","orcid":"https://orcid.org/0000-0001-8201-7815","observed_orcids":["https://orcid.org/0000-0001-8201-7815"]},"institutions":[{"id":"https://openalex.org/I2802753785","display_name":"Mackay Memorial Hospital","ror":"https://ror.org/015b6az38","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2802753785"]},{"id":"https://openalex.org/I4210119458","display_name":"Roche (China)","ror":"https://ror.org/02hv5e369","country_code":"CN","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210119458"]}],"countries":["CN","TW"],"is_corresponding":false,"raw_author_name":"Haiyan Wang","raw_affiliation_strings":["11Mackay Memorial Hospital, Taipei City, Taiwan","18Roche Product Development, Shanghai, People\u2019s Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Mackay Memorial Hospital, Taipei City, Taiwan","institution_ids":["https://openalex.org/I2802753785"]},{"raw_affiliation_string":"18Roche Product Development, Shanghai, People\u2019s Republic of China","institution_ids":["https://openalex.org/I4210119458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079797317","display_name":"Fran\u00e7ois Lamour","orcid":"https://orcid.org/0000-0002-1020-5793","observed_orcids":["https://orcid.org/0000-0002-1020-5793"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Lamour","raw_affiliation_strings":["19F. Hoffmann-La Roche Ltd, Basel, Switzerland. Current affiliation: Alentis Therapeutics, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19F. Hoffmann-La Roche Ltd, Basel, Switzerland. Current affiliation: Alentis Therapeutics, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103435739","display_name":"Grace Y. Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267739","display_name":"Hangzhou Tigermed Consulting Co., Ltd. (China)","ror":"https://ror.org/0441h8w87","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267739"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Grace Song","raw_affiliation_strings":["20Biometrics, Hangzhou Tigermed Consulting Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Biometrics, Hangzhou Tigermed Consulting Co., Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4405267739"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068222768","display_name":"Eleonora Restuccia","orcid":"https://orcid.org/0000-0001-5751-094X","observed_orcids":["https://orcid.org/0000-0001-5751-094X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Eleonora Restuccia","raw_affiliation_strings":["21Product Development Oncology - F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Product Development Oncology - F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":21,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"PD18","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9240000247955322},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.7940000295639038},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dual-her2-blockade","display_name":"dual HER2 blockade","score":0.8080000281333923},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9020000100135803},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8730000257492065},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8640000224113464},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9860000014305115},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.7910000085830688},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.6039999723434448},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.628000020980835},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8668258190155029},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.8359019160270691},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7393138408660889},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.679329514503479},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.6527826189994812},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6510491967201233},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6284298896789551},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5511019229888916},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5420868992805481},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5220599174499512},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.459597647190094},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.44835904240608215},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.43328115344047546},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4331139624118805},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3696194887161255},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32765674591064453},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2702937722206116},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2668219208717346},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10815414786338806},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-pd18-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd18-03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-pd18-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392623714","https://openalex.org/W2944498830","https://openalex.org/W2379981061","https://openalex.org/W2921367120","https://openalex.org/W3199640643","https://openalex.org/W4206891336","https://openalex.org/W2889791637","https://openalex.org/W1982825879","https://openalex.org/W2767724128","https://openalex.org/W2123591186"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"In":[2],"the":[3,30,55,87,94,108,177,253,268,271,279,285,294,320,337,344,400,432,443,450,455,458,518,550],"Phase":[4,61,519],"II":[5],"NeoSphere":[6],"study":[7,387],"(NCT00545688),":[8],"dual":[9],"HER2":[10],"blockade":[11],"with":[12,46,73,86,411,431,442,538],"pertuzumab":[13,529],"(P)":[14],"+":[15,18],"trastuzumab":[16,533],"(H),":[17],"docetaxel":[19],"(D)":[20],"significantly":[21,66],"increased":[22],"pathologic":[23],"complete":[24],"response":[25],"(pCR)":[26],"vs.":[27,75,307,311,317,341,413],"H+D":[28,76],"in":[29,77,176,267,278,284,301,329,336,343,351,461,536],"neoadjuvant":[31,134],"setting":[32,179],"for":[33,180,421],"HER2-positive":[34,115,462,539],"early":[35,540],"breast":[36,544],"cancer":[37,545],"(EBC),":[38],"locally":[39,542],"advanced":[40,543],"(LA)":[41],"BC,":[42,45],"or":[43,119,123,136,174,370,372,380,530,541],"inflammatory":[44],"supportive":[47,398],"progression-":[48],"and":[49,81,102,105,128,166,206,215,226,241,282,313,353,395,405,418,437,525,534],"disease-free":[50],"survival":[51,188,192],"(DFS)":[52],"data.":[53],"Consistently,":[54],"randomized,":[56],"multicenter,":[57],"double-blind,":[58],"placebo":[59],"(Pla)-controlled":[60],"III":[62,369,520],"PEONY":[63,447,521],"trial":[64],"(NCT02586025)":[65],"improved":[67],"total":[68],"pCR":[69],"(tpCR;":[70],"primary":[71,359,401],"endpoint)":[72],"P+H+D":[74,135,280,338,459],"an":[78],"Asian":[79],"population,":[80],"safety":[82,90,106,435,526],"data":[83,264,428,453,468],"were":[84,129,197,229,239,247,349,397,429],"in-line":[85,430],"known":[88,433],"P":[89,434],"profile.":[91],"We":[92],"present":[93],"final":[95],"analysis":[96,516],"of":[97,172,276,299,327,355,375,399,424,445,452,457,517,527,549],"long-term":[98,523],"efficacy":[99,263,391,467,524],"(at":[100],"3":[101,140],"5":[103],"years)":[104],"from":[107],"study.":[109],"METHODS":[110],"Patients":[111,160],"had":[112],"centrally":[113],"confirmed":[114],"EBC":[116],"(T2\u20133,":[117,121],"N0\u20131)":[118],"LABC":[120],"N2":[122],"N3;":[124],"T4,":[125],"any":[126,386],"N)":[127],"randomized":[130],"2:1":[131],"to":[132,182,232,235,449],"four":[133],"Pla+H+D":[137,286,345],"cycles":[138],"every":[139],"weeks.":[141],"P:":[142],"840":[143],"mg":[144,146],"loading/420":[145],"maintenance":[147],"doses":[148],"(or":[149],"Pla);":[150],"H:":[151],"8":[152],"mg/kg":[153,155],"loading/6":[154],"maintenance;":[156],"D:":[157],"75":[158],"mg/m2.":[159],"then":[161],"received":[162,252],"three":[163],"fluorouracil,":[164],"epirubicin,":[165],"cyclophosphamide":[167],"cycles,":[168],"followed":[169],"by":[170,199,212],"13":[171],"P+H":[173,412],"Pla+H":[175,414],"adjuvant":[178],"up":[181],"1":[183],"year.":[184],"Long-term":[185,262,390,466],"outcomes":[186],"(event-free":[187],"[EFS],":[189],"DFS,":[190,394],"overall":[191,272],"[OS];":[193],"all":[194],"secondary":[195,381],"endpoints)":[196],"assessed":[198],"Kaplan\u2013Meier":[200],"methods,":[201],"Cox":[202],"proportional":[203],"hazards":[204],"models,":[205],"a":[207,407],"two-sided":[208],"log-rank":[209],"test":[210],"(stratified":[211],"disease":[213],"category":[214],"hormone":[216],"receptor":[217],"status).":[218],"RESULTS":[219],"Data":[220],"cut-off":[221],"was":[222,259,333],"Mar":[223],"14,":[224],"2022,":[225],"329":[227],"patients":[228,251,277,300,328,537],"randomized;":[230],"219":[231],"P;":[233],"110,":[234],"Pla.":[236],"Safety":[237,427],"populations":[238],"218":[240],"110":[242],"patients,":[243,356],"respectively.":[244,357],"Baseline":[245],"characteristics":[246],"well":[248],"balanced.":[249],"Most":[250],"full":[254],"HER2-targeted":[255],"cycles.":[256],"Median":[257],"follow-up":[258],"62.9":[260],"months.":[261],"are":[265],"shown":[266],"table.":[269],"During":[270],"treatment":[273],"period,":[274],"70.6%":[275],"arm":[281,287,339],"68.2%":[283],"experienced":[288],"grade":[289,368],"\u22653":[290],"adverse":[291],"events":[292,361,383],"(AEs);":[293],"most":[295,321],"common":[296,322,335],"(in":[297,325],"\u22655%":[298],"either":[302,330],"arm)":[303],"being":[304],"neutropenia":[305,315],"(59.2%":[306],"55.5%),":[308],"leukopenia":[309],"(34.4%":[310],"34.5%),":[312],"febrile":[314],"(5.0%":[316],"3.6%).":[318],"Of":[319],"any-grade":[323],"AEs":[324,348],"\u226530%":[326],"arm),":[331],"diarrhea":[332],"more":[334],"(40.8%":[340],"17.3%":[342],"arm).":[346],"Serious":[347],"reported":[350],"17.0%":[352],"13.6%":[354],"No":[358],"cardiac":[360,382],"(heart":[362],"failure":[363],"[New":[364],"York":[365],"Heart":[366],"Association":[367],"IV]":[371],"significant":[373],"decline":[374],"left":[376],"ventricular":[377],"ejection":[378],"fraction)":[379],"occurred":[384],"during":[385],"periods.":[388],"CONCLUSIONS":[389],"endpoints":[392],"(EFS,":[393],"OS)":[396],"endpoint":[402],"results":[403],"(tpCR)":[404],"suggested":[406],"clinically":[408],"meaningful":[409],"improvement":[410],"when":[415],"administered":[416],"before":[417],"after":[419],"surgery":[420],"one":[422],"year":[423],"anti-HER2-":[425],"therapy.":[426],"profile":[436],"generally":[438],"comparable":[439],"between":[440],"arms,":[441],"exception":[444],"diarrhea.":[446],"adds":[448],"totality":[451],"showing":[454],"benefit":[456],"regimen":[460],"EBC.":[463],"Table":[464],"1:":[465],"Citation":[469],"Format:":[470],"Zhi-Ming":[471],"Shao,":[472],"Da":[473],"Pang,":[474],"Hongjian":[475],"Yang,":[476],"Wei":[477],"Li,":[478],"Shusen":[479],"Wang,":[480,486,488,492,508],"Shude":[481],"Cui,":[482],"Ning":[483],"Liao,":[484],"Yong-Sheng":[485],"Chuan":[487],"Yuan-Ching":[489],"Chang,":[490],"Hwei-Chung":[491],"Seok":[493],"Yun":[494],"Kang,":[495],"Jae":[496],"Hong":[497],"Seo,":[498],"Kunwei":[499],"Shen,":[500],"Suphawat":[501],"Laohawiriyakamol,":[502],"Zefei":[503],"Jiang,":[504],"Liang":[505],"Huang,":[506],"Haiyan":[507],"Fran\u00e7ois":[509],"Lamour,":[510],"Grace":[511],"Song,":[512],"Eleonora":[513],"Restuccia.":[514],"Final":[515],"trial:":[522],"neoadjuvant\u2013adjuvant":[528],"placebo,":[531],"plus":[532],"docetaxel,":[535],"[abstract].":[546],"In:":[547],"Proceedings":[548],"2022":[551,557],"San":[552,560],"Antonio":[553],"Breast":[554],"Cancer":[555,566],"Symposium;":[556],"Dec":[558],"6-10;":[559],"Antonio,":[561],"TX.":[562],"Philadelphia":[563],"(PA):":[564],"AACR;":[565],"Res":[567],"2023;83(5":[568],"Suppl):Abstract":[569],"nr":[570],"PD18-03.":[571]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2023-03-03T00:00:00"}